


Domain Therapeutics and Merck enter into a license and collaboration agreement

GPCR: Domain Therapeutics grants Alkermes a non-exclusive license for its BioSens-All™ technology

French technology clusters Route des Lasers and Elopsys merge to become ALPHA-RLH
